Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
InvaGen has received 5 inspectional observations in Form 483
The market capitalization of the company stood at Rs. 7,000 crore +
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Subscribe To Our Newsletter & Stay Updated